Table 2.
Placebo | Testosterone | P value | Controls | P value | ||
---|---|---|---|---|---|---|
placebo vs testosterone | placebo vs controls | |||||
CT | Total abdominal fat cm3 | 533 ± 408 | 495 ± 366 | 0.04 | 194 ± 142 | <0.001 |
Intra-abdominal fat cm3 | 233 ± 163 | 223 ± 166 | 0.5 | 82 ± 79 | <0.001 | |
Ratio visceral vs total fat | 0.46 ± 0.12 | 0.46 ± 0.13 | 0.4 | 0.43 ± 0.17 | 0.4 | |
DEXA | Total body fat (kg) | 26.8 ± 16.8 | 24.6 ± 15.3 | 0.01 | 21.3 ± 15.2 | 0.1 |
Abdominal fat (kg) | 7.8 ± 5.8 | 7.2 ± 5.1 | 0.05 | 5.4 ± 4.6 | 0.06 | |
Abdominal lean body mass (g) | 16.6 ± 4.9 | 17.0 ± 4.3 | 0.5 | 15.7 ± 3.5 | 0.3 | |
Abdominal total mass (g) | 24.7 ± 10.6 | 24.3 ± 8.9 | 0.4 | 21.4 ± 8.1 | 0.1 | |
Abdominal fat (%) | 29.9 ± 14.9 | 28.1 ± 16.8 | 0.03 | 24.5 ± 11.1 | 0.1 | |
Visceral fat (g) | 3.5 ± 2.4 | 3.3 ± 2.3 | 0.2 | 2.3 ± 1.9 | 0.05 | |
Total body lean mass (g) | 61.1 ± 12.1 | 62.1 ± 10.7 | 0.09 | 64.0 ± 13.0 | 0.4 | |
Total lumbar BMD (g/cm2) | 0.98 ± 0.29 | 0.98 ± 0.27 | 0.5 | 1.11 ± 0.23 | 0.02 | |
Total hip BMD (g/cm2) | 0.99 ± 0.16 | 0.99 ± 0.19 | 0.7 | 1.07 ± 0.22 | 0.1 | |
Muscle strength | Arm – right biceps (Nm) | 300 ± 41 | 301 ± 50 | 0.9 | 322 ± 49 | 0.08 |
Leg – right quadriceps (Nm) | 557 ± 121 | 556 ± 140 | 1.0 | 627 ± 115 | 0.2 | |
Bio-chemistry | Testosterone (nmol/L) | 10.2 ± 5.5 | 8.5 ± 4.1 | 0.2 | 17.4 ± 5.0 | 0.002 |
DHEAS (nmol/L) | 4.7 ± 2.3 | 4.0 ± 1.8 | 0.02 | 5.9 ± 3.2 | 0.3 | |
17-Hydroxy-progesterone (nmol/L) | 2.5 ± 1.3 | 1.8 ± 1.0 | 0.02 | 2.8 ± 1.2 | 0.5 | |
Androstenedione (nmol/L) | 2.9 ± 1.0 | 2.8 ± 0.8 | 0.7 | 3.5 ± 1.5 | 0.3 | |
LH (IU/L) | 19.6 ± 5.1 | 19.1 ± 5.2 | 0.7 | 4.0 ± 1.4 | <0.0001 | |
FSH (IU/L) | 36.9 ± 9.1 | 35.7 ± 11.2 | 0.4 | 3.9 ± 1.6 | <0.0001 | |
SHBG (nmol/L) | 31.6 ± 13.8 | 24.5 ± 10.6 | 0.001 | 30.3 ± 9.6 | 0.8 | |
Hemoglobin (mmol/L) | 8.7 ± 0.6 | 9.0 ± 0.6 | 0.05 | 9.6 ± 0.6 | 0.001 | |
IGF-I (µg/L) | 163 ± 51 | 178 ± 47 | 0.03 | 165 ± 54 | 0.9 | |
IGFBP-3 (µg/L) | 4329 ± 794 | 4155 ± 710 | 0.2 | 3707 ± 397 | 0.02 | |
CRP (mg/L) | 1.7 ± 1.7 | 2.1 ± 2.3 | 0.3 | 1.6 ± 1.6 | 1.0 | |
Total cholesterol (mmol/L) | 4.7 ± 0.7 | 4.6 ± 0.8 | 0.6 | 4.9 ± 0.9 | 0.4 | |
LDL cholesterol (mmol/L) | 2.7 ± 0.8 | 2.7 ± 1.0 | 1.0 | 2.8 ± 1.1 | 0.9 | |
HDL cholesterol (mmol/L) | 1.3 ± 0.4 | 1.2 ± 0.6 | 0.4 | 1.3 ± 0.3 | 0.9 | |
Triglycerides (mmol/L) | 1.3 ± 0.8 | 1.5 ± 0.6 | 0.4 | 1.3 ± 0.5 | 0.9 | |
Alanine aminotransferase (U/L) | 36 ± 23 | 27 ± 11 | 0.1 | 42 ± 32 | 0.5 | |
Blood Pressure | Day systolic AMBP | 125 ± 13 | 129 ± 9 | 0.2 | 129 ± 10 | 0.4 |
Night systolic AMBP | 112 ± 12 | 113 ± 11 | 0.8 | 114 ± 10 | 0.7 | |
24-h systolic AMBP | 122 ± 9 | 124 ± 9 | 0.2 | 125 ± 8 | 0.4 | |
Day diastolic AMBP | 77 ± 9 | 82 ± 13 | 0.8 | 80 ± 9 | 0.4 | |
Night diastolic AMBP | 66 ± 10 | 65 ± 10 | 0.8 | 65 ± 10 | 0.9 | |
24-h diastolic AMBP | 74 ± 7 | 75 ± 7 | 0.4 | 76 ± 9 | 0.6 | |
Exercise capacity | VO2max (mL O2/kg/min) | 33.1 ± 7.3 | 31.3 ± 7.4 | 0.1 | 45.2 ± 6.6 | 0.004 |